mercaptopurine and Telangiectasis

mercaptopurine has been researched along with Telangiectasis* in 1 studies

Other Studies

1 other study(ies) available for mercaptopurine and Telangiectasis

Article	Year
Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine. Journal of drugs in dermatology : JDD, 2017, Mar-01, Volume: 16, Issue:3 Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only pre-existing vessels. This new view of GET may drive others to look at novel agents for treatment. J Drugs Dermatol. 2017;16(3):280-282. . Topics: Antigens, CD34; Antimetabolites, Antineoplastic; Biomarkers; Colitis, Ulcerative; Collagen Type IV; Endothelial Cells; Female; Fibrinogen; Humans; Lasers, Dye; Low-Level Light Therapy; Mercaptopurine; Metalloproteases; Middle Aged; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Telangiectasis	2017

Article

Year

Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine.

Journal of drugs in dermatology : JDD, 2017, Mar-01, Volume: 16, Issue:3

Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only pre-existing vessels. This new view of GET may drive others to look at novel agents for treatment.

J Drugs Dermatol. 2017;16(3):280-282.

Topics: Antigens, CD34; Antimetabolites, Antineoplastic; Biomarkers; Colitis, Ulcerative; Collagen Type IV; Endothelial Cells; Female; Fibrinogen; Humans; Lasers, Dye; Low-Level Light Therapy; Mercaptopurine; Metalloproteases; Middle Aged; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Telangiectasis

2017